---
title: "Matinas BioPharma surges 37% in regular trading on volume spike"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293943308.md"
description: "Matinas BioPharma (MTNB) jumped 37% during regular trading, triggering a 5-minute surge alert."
datetime: "2026-07-27T13:50:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293943308.md)
  - [en](https://longbridge.com/en/news/293943308.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293943308.md)
generator: "portal-rs"
---

# Matinas BioPharma surges 37% in regular trading on volume spike

Matinas 生物制药 (MTNB.US) 盘中急涨**37.41%**，现报**0.3317 美元**。

### Related Stocks

- [MTNB.US](https://longbridge.com/en/quote/MTNB.US.md)

## Related News & Research

- [Billionaire Stanley Druckenmiller Continues to Load Up on Revolution Medicines. Does He Know Something Wall Street Doesn't?](https://longbridge.com/en/news/296885075.md)
- [Rhythm Pharmaceuticals (RYTM) Could Be 15% Undervalued As Japan Approval Lifts Its Story](https://longbridge.com/en/news/297007083.md)
- [Why Arcus Biosciences (RCUS) Is Getting Attention Today](https://longbridge.com/en/news/296943867.md)
- [AstraZeneca Stock Leads 3 Cash Flow Picks Trading Below Fair Value](https://longbridge.com/en/news/296923180.md)
- [SCYNEXIS grants new senior director stock options for 20,000 shares at USD 5.26](https://longbridge.com/en/news/297027079.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**